Skip to main content

About Farzaneh Daghigh

Farzaneh Daghigh received her PhD in biochemistry from Temple University, School of Medicine. Later, she conducted postdoctoral research at the DuPont-Merck Pharmaceuticals. She then joined the faculty at the Philadelphia College of Osteopathic Medicine as an Assistant Professor in 1998. Currently, she is a full Professor of Biochemistry in the Department of Bio-Medical Sciences at PCOM.

Dr. Daghigh is the biochemistry content expert in the pre-clinical curriculum. She teaches biochemistry and nutrition to medical students and graduate students. She serves as the co-course director of the Culinary Medicine elective and the Cellular and Molecular Basis of Medicine (CMBM) course. Dr. Daghigh’s passion is helping students understand, appreciate, and integrate the basic sciences to remain as inquisitive physicians during their lifelong medical practice.

Dr. Daghigh believes in engaging students in their own learning and developed many collaborative active learning sessions. Her medical education research is geared towards the goal of inclusion of nutrition in the DO curriculum and the use of nutrition education and behavior change in individuals with overweight, obesity and metabolic syndrome. She also studies the effects of omega-3 fatty acids on arginine metabolism in airway remodeling in asthmatic patients.


Present Professor of Biochemistry, Philadelphia College of Osteopathic Medicine Department of Bio-Medical Sciences



2008 - 2009 Determination of the physiologically and pathophysiologically relevance of arginase isoforms in NO production by human gingival fibroblasts
Role: PI
2007 - 2008 Documenting Mechanics and Mechanisms in Pedal Pump OMT
AOA - 07-10-557
Role: Co-PI
2006 - 2007 Pilot: Gait Analysis, Balance, Nitric Oxide, Fluid Distribution, and Quality-of-Life of Patients with Parkinson’s Disease (PD) treated with Whole Body, Periodic Acceleration or Osteopathic Manipulative Treatment (OMT)
Korman’s Foundation
Role: Co-PI
2003 - 2004 A pilot study to establish a protocol to determine the change in nitric oxide (NO) concentrations after treatment with the Accelerated Therapeutic 101 (AT101) table in normal healthy subjects and patient volunteers
Karen and Herbert Lotman Foundation
Role: Co-PI
Enter a valid date range.

Enter a valid date range.


  • MBM
  • Life Stages
  • Gastroenterology
  • Cardiovascular Diseases
  • CMBM


1995 PhD, Temple University School of Medicine ‐ Department of Biochemistry
1988 BS, The College of New Jersey ‐ Chemistry

Contact Information

P: 215-871-6449


Scholarly Articles (8)

Contributions to Books (1)

Conferences and Presentations (9)

Poster Presentations and Instructional Resources (1)